Digital outcomes

Anat Mirelman, Tanya Simuni

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Recent years have witnessed an increasing interest in digital health technology (DHT) within neurology (sensors, devices, specific smartphone apps) and specifically in Parkinson's disease (PD). Quantitative measures derived from digital technology have the potential to close the gap between the different assessment properties providing measures that can quantitatively and continuously monitor PD symptoms outside the clinics, that are important to patients and reflect a pathological process or response to treatment (biomarker). This chapter reviews the current state of the field and necessary next steps to position DHT as clinically and regulatory accepted outcomes in PD.

Original languageEnglish
Title of host publicationHandbook of Digital Technologies in Movement Disorders
Number of pages17
ISBN (Electronic)9780323994941
ISBN (Print)9780323994958
StatePublished - 1 Jan 2024


  • Biomarkers
  • Clinical outcomes assessment
  • Digital technology
  • Endpoints
  • Patients reported outcomes


Dive into the research topics of 'Digital outcomes'. Together they form a unique fingerprint.

Cite this